This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Organogenesis, Inc.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: The Innovative Contributions of Jianjian Jin
Jianjian Jin is a notable inventor based in Quincy, MA (US). He has made significant strides in the field of biotechnology, particularly in the area of diabetes treatment. His work focuses on developing innovative solutions that can improve the quality of life for diabetic patients.
Latest Patents
Jin holds a patent for "Cultured cells from pancreatic islets." This patent describes a cell composition of endocrine progenitor cells derived from mammalian pancreatic islet cells. These cells can be transplanted into diabetic patients, where they differentiate into functioning insulin-producing beta cells. This innovation has the potential to transform diabetes management and treatment.
Career Highlights
Jianjian Jin is currently employed at Organogenesis, Inc. His role at the company allows him to contribute to groundbreaking research and development in regenerative medicine. His expertise in cell biology and transplantation has positioned him as a key player in the field.
Collaborations
[Section skipped due to space constraints.]
Conclusion
Jianjian Jin's contributions to the field of biotechnology, particularly through his patent on cultured pancreatic islet cells, highlight his innovative spirit and dedication to improving healthcare solutions. His work at Organogenesis, Inc. continues to pave the way for advancements in diabetes treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile